Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti ☰
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Fluoxetina

Prozac, Fluoxeren e altri

Bibliografia - Quali fonti bibliografiche per Fluoxetina?

  1. Abman S.H., Pediatr. Pulmonol. Suppl., 1999, 18, 201.

  2. Adly C. et al., Headache, 1992, 32 (2), 101.

  3. Amore M. et al., Hum. Psychopharmacol. Clin. Exper., 1999, 14 (6), 429.

  4. Arnold L.M. et al., Am. J. Med., 2002, 112, 191.

  5. BMJ, 1999, 319, 1106.

  6. Caimi V., Medicina Generale UTET, 2003, pag 372.

  7. Carruba M.O. et al. in Int. Symp. on Serotonin from Cell Biology to Pharmacology and Therapeutics, 1989, Firenze, p.124.

  8. Casper R.C. et al., J. Pediatr., 2003, 142, 402.

  9. Chambers C.D. et al., NEJM, 2006, 354, 579.

  10. D’Amato C.C. et al., Headache, 1999, 39 (10), 716.

  11. Dalton S.O. et al., Arch. Intern. Med., 2003, 163, 59.

  12. Diav-Citrin O. et al., Br. J. Clin. Pharmacol., 2008, 66 (5), 695.

  13. DTB, Drug Therapeutics Bullettin, 2008, 46 (4), 25, (Ed. italiana).

  14. Expertise Collective Inserm, Les édition Inserm: Paris; 2003.

  15. Ferguson J.M., Am. J. Psichiatr., 1986, 143, 1496.

  16. Freeman C.P.L., Hampson M., Int. J. Obes., 1987, 11 (Suppl. 3), 171.

  17. Garattini S. et al., in Int. Symp. on Serotonin from Cell Biology to Pharmacology and Therapeutics, 1989, Firenze, p.124.

  18. Gilman J.T., Tuchman R.F., Ann. Pharmacother.,1995, 29, 47.

  19. Goldenberg D. et al., Arthritis Rheum., 1996, 39, 1852.

  20. Gorman J.M. et al., J. Clin. Psychopharmacol., 1987, 7 (5), 329.

  21. Gossen D. et al., AAPS Pharm. Sci., 2002, 4, E11.

  22. Grubb B.P. et al., Am. J. Med., 1994, 97, 366.

  23. Gulseren L. et al., Arch. Med. Res., 2005, 36 (2), 159.

  24. Jureidini J.N. et al., BMJ, 2004, 328, 879.

  25. Kirby D. et al., Internet J. Ger. Psychiatry, 2002, 17, 231.

  26. Laine K. et al., Arch. Gen. Psychiatry, 2003, 60, 720.

  27. Layton D. et al., Eur. J. Clin. Pharmacol., 2001, 57, 167.

  28. Levine L.R. et al., Ibidem, 1987, 46, 185.

  29. Loprinzi C.L. et al., J. Clin. Oncol., 2002, 20, 1578.

  30. Malm H. et al., Obstet. Gynecol., 2005, 106, 1289.

  31. Mason P.J. et al., Medicine, 2000, 79, 201.

  32. Michelson D. et al., Am. J. Psychiatry, 1998, 155 (11), 1570.

  33. Mills K.C., Critical Care Clinics, 1997, 13, 763.

  34. Mills J.L., NEJM, 2006, 354, 636.

  35. Morag I. et al., J. Toxicol. Clin. 2004, 42, 97.

  36. Movig K.L. et al., Arch. Intern. Med., 2003, 163, 2354.

  37. Nulman I. et al., NEJM, 1997, 336, 258.

  38. Nulman I. et al., Am. J. Psychiatry, 2002, 159, 1889.

  39. Oberlander T.F. et al., Pediatr. Res., 2002, 51, 443.

  40. Orlova Y. Et al., JAMA Neurol., 2018, doi: 10.1001/jamaneurol.2017.5144.

  41. Patron C. Ferrier I.N., BMJ, 2005, 334, 529.

  42. Patterson W.M., J. Clin. Psychiatry, 1993, 54, 71.

  43. Pearlstein T.B. et al., J. Clin. Psychopharmacol., 1997, 17 (4), 261.

  44. Saletu B., Gruenberger J., J. Clin. Psych., 1985, 46, 45.

  45. Sansone R.A., Sansone L.A., Int. J. Psychiatry Med., 2003, 33 (1), 103.

  46. Saper J.R. et al., Headache, 1994, 34 (9), 497.

  47. Schmidt M.E. et al., J. Clin. Psychiatry, 2000, 61, 851.

  48. Serebruany V.L. et al., Am. J. Med., 2006, 119, 113

  49. Steiner M. et al., Psychopharmacol. Bull., 1997, 33 (4), 771.

  50. Steiner M. et al., NEJM, 1995, 332 (23), 1529.

  51. Suvanto-Luukkonen E. et al., Menopause, 2005, 12, 18.

  52. Tohen M. et al., Arch. Gen. Psychiatry, 2003, 60 (11), 1079.

  53. van Walraven C. et al., BMJ, 2001, 323, 655.

  54. Wagner K.D. et al., JAMA, 2003, 290, 1033.

  55. Zerbe R.L., Int. J. Obes., 1987, 11 (Suppl. 3), 191.

  56. Zeskind P.S., Stephens L.E., Pediatrics, 2004, 113, 368.

  57. Zeskind P.S. et al., Pediatr. Res., 2005, 57, 1624.

Link
BMJ, British Medical Journal
www.bmj.com

  1. “Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study” BMJ 2010;340:c693, doi: 10.1136/bmj.c693
  2. “Managing and preventing depression in adolescente” BMJ 2010;340:c209, doi: 10.1136/bmj.c209
  3. “Long QT sindrome” BMJ 2010;340:b4815, doi: 10.1136/bmj.b4815 (Published 8 January 2010)
  4. “SSRIs and heart defects in neonates” BMJ 2009;339:b4288, doi: 10.1136/bmj.b4288 (Published 21 October 2009)

The Lancet
www.thelancet.com

  1. Current practice and future directions in the prevention and acute management of migraine
    The lancet Neurologo, 2010, 9(3), 285.
  2. Eating disorders, The lancet, 2010, 375 (9714), 583
  3. Probabile fluoxetine-induced carotidynia, The Lancet, 2009, 374 (9695), 1061.